How does the hunger-suppressing hormone leptin cross the blood-brain barrier?
Specialized cells called pericytes play a key role, reveals new work from researchers at the RI-MUHC
RI-MUHC study explores how to overcome the resistance of bladder tumours to radiation therapy
Work published in Nature Communications demonstrates a...
RI-MUHC-led team receives $3.4M for new Centre for Applied Nanomedicine
The study of exosomes will foster research on the frontier of personalized medicine
RI-MUHC veterinarians engage in global effort to understand SARS-Cov-2
ARD platform members take centre stage at the 2020 Quebec Veterinary Congress
Paving the way for COVID-19 research
RI-MUHC and McGill Containment level 3 Labs receive $1M in funding to accelerate research with live SARS Cov-2
Containment Level 3 facilities advance COVID-19 research at the RI-MUHC and McGill
Infrastructure to study COVID-19 in a secure environment is creating new possibilities for collaboration and discovery
The RI-MUHC receives and tests the first UV-Disinfection robot in Canada
Novel robotics technology could potentially reduce healthcare-associated infections
Jean-François Trempe appointed Director of the Proteomics Platform, RI-MUHC
The new mandate is effective February 1, 2020
Meeting the global health challenge of worms that cause disease
Theresa Gyorkos has dedicated her career to understanding and reducing the harms caused by parasitic worm infection
Brain cancer: An intelligent molecule to fool and kill glioblastoma cells
An RI-MUHC research team is working to extend lives of patients with an incurable cancer